DECLINE OF PREVALENCE OF RESISTANCE ASSOCIATED SUBSTITUTIONS TO NS3 AND NS5A INHIBITORS AT DAA-FAILURE IN HEPATITIS C VIRUS IN ITALY OVER THE YEARS 2015 TO 2018